CDXS - Codexis and Aldevron sign exclusive licensing deal for Codex HiCap RNA polymerase
2023-12-13 16:20:24 ET
More on Codexis, Danaher, etc.
- Danaher Corporation (DHR) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Danaher Corporation: A Good Contrarian Bet
- Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
- Goldman Sachs projects a rebound in life sciences tools space
- Abcam gains after securing all approvals for Danaher sale, set to close Dec. 6
For further details see:
Codexis and Aldevron sign exclusive licensing deal for Codex HiCap RNA polymerase